Peptide Companion
Back to catalog
Peptide Companion
single
Growth Hormone
Vial: 2 mg

GHRP-6 (2 mg Vial)

GHRP-6 (Growth Hormone-Releasing Peptide 6) is a synthetic hexapeptide that functions as a potent growth hormone secretagogue by binding to the ghrelin receptor (GHS-R1a). It stimulates pulsatile GH release from the pituitary gland while maintaining physiological feedback controls, resulting in elevated IGF-1 levels and potential anabolic benefits. This educational protocol presents a three-times-daily subcutaneous approach using practical dilution for precise insulin-syringe measurements.

Dose
0.1–0.3 mg per injection
Frequency
2–3 times daily
Timing
Morning, post-workout, before bed
Duration
8–12 weeks

Strong ghrelin activity. Significant appetite increase. First-generation GHRP.

Dosing Schedule
Week/PhaseDose per Injection (mcg)Units (per injection) (mL)
Weeks 1–2100 mcg15 units (0.15 mL)
Weeks 3–4200 mcg30 units (0.30 mL)
Weeks 5–12300 mcg45 units (0.45 mL)
Supplies Needed
  • •Peptide Vials (GHRP-6, 2 mg each):
  • •Insulin Syringes (U-100):
  • •Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
  • •Alcohol Swabs: One for the vial stopper + one for the injection site per injection.
References

  • European Journal of Endocrinology (1997)

    Growth hormone-releasing peptides: comprehensive review of GHRP mechanisms and effects

    View source

  • Clinical Medicine Insights: Cardiology (2017)

    Synthetic GHRPs: historical appraisal of cytoprotective effects and mechanisms

    View source

  • Wikipedia

    GHRP-6: structure, pharmacology, and mechanism of action overview

    View source

  • European Journal of Pharmaceutical Sciences (2013)

    Pharmacokinetic study of GHRP-6 in healthy male volunteers

    View source

  • European Journal of Endocrinology (1997)

    Pulsatile GH secretion and feedback mechanisms with GHRPs

    View source

  • Clinical Medicine Insights: Cardiology (2017)

    Effect of nutrient intake on GHRP-induced GH release

    View source

  • Sexual Medicine Reviews (2018)

    Safety and efficacy of growth hormone secretagogues

    View source

  • Assay Genie Product Datasheet (2021)

    GHRP-6 recombinant protein: storage and handling recommendations

    View source

  • CDC (2024)

    Preventing unsafe injection practices: basic injection safety guidelines

    View source

  • CDC (2024)

    4 ways to take insulin: injection sites and rotation strategies

    View source

  • Clinical Medicine Insights: Cardiology (2017)

    Ghrelin receptor activation and orexigenic effects of GHRP-6

    View source

  • Wikipedia

    GHRP-6 mechanism: ghrelin receptor binding and GH secretagogue activity

    View source

  • Clinical Medicine Insights: Cardiology (2017)

    CD36 receptor activation and cell-survival signaling pathways

    View source

  • International Wound Journal (2018)

    GHRP-6 prevents cutaneous hypertrophic scarring: proteome study

    View source

  • Sexual Medicine Reviews (2018)

    GH secretagogues: effects on lean body mass and fat reduction

    View source

  • Clinical Medicine Insights: Cardiology (2017)

    GHRP effects on sleep architecture and slow-wave sleep

    View source

  • Clinical Medicine Insights: Cardiology (2017)

    Cardioprotective and neuroprotective effects of GHRPs in preclinical models

    View source

  • Clinical Medicine Insights: Cardiology (2017)

    Transient ACTH and cortisol elevation with GHRP-6 administration

    View source

  • Sexual Medicine Reviews (2018)

    Safety profile of growth hormone secretagogues in human trials

    View source

  • CDC (2024)

    Vaccine administration: subcutaneous injection technique (fact sheet)

    View source

  • CDC (2024)

    Vaccine administration: during vaccination best practices

    View source

  • Clinical Diabetes (2019)

    The injection technique factor: what you don’t know or teach can make a difference

    View source

Educational content adapted from peptidedosages.com. Not medical advice.